Arena Recommended For Approval
Posted on May 11, 2012 at 14:50 PM EDT
A Food and Drug Administration advisory committee recommended approval for Arena Pharmaceuticals Inc.'s (Nasdaq: ARNA) obesity treatment Lorcaserin. The stock price surged $2.80 to $6.46.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here